Pioneer Natural Resources (PXD) Pops on Buy Rating, Bullish Shale Outlook

Michael Teague |

Pioneer Natural Resources ($PXD), the $27.5 billion independent oil & gas producer based in Irving, Texas, saw shares trading much higher in Wednesday's action.

Shares for Prioneer spiked over 7 percent in midday trading to $213.75, after the company received a “buy” rating from analysts at Raymond James. It is not hard to see why, either, as the company has presence in some of the US’s most promising shale plays, the Spraberry/Wolfcamp shale located near Midland, Texas.

Pioneer estimates that the Spraberry field contains some 50 billion barrels of oil equivalent, which would make it the largest known shale reserve not only in the US, but also one of the largest in the world. If the 50 billion barrel estimates proves out, Spraberry would be nearly twice as large as the much vaunted Eagle Ford shale, whose reserves are estimated at just over 26 billion barrels.

Much of this has to do with the fact that the Spraberry/Wolfcamp concern has what is called in industry parlance “stacked pay potential,” which simply means that the oil and gas hidden underneath the earth is stacked in various layers of shale. This makes for very nice drilling conditions, as one vertical well can be applied to several formations at once.

While it is common practice for oil companies to exaggerate numbers such as the amount of potential reserves they believe they will unlock from a particular play, other independents who are working in the region have also been giving similar estimates of late, making it more likely that Spraberry could likely become one of the most coveted plays, surpassing not only the Eagle Ford shale, but also others such as the Bakken and Marcellus shales.

Independent drillers and producers have so far been the The spike for Pioneer brought shares of other independents along with it. Diamondback Energy (FANG) was up 6.75 percent to $50, Clayton Williams Energy  (CWEI) gained 5.70 percent to $66.50, and Vaalco Energy (EGY) has all gained over five percent heading towards the closing bell.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Spotlight

BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.

Events

EQUITIES Emerging Growth and Innovation Forum

EQUITIES Inaugural Emerging Growth and Innovation Forum at Disruptive firm MRY New York City's Flatiron District. The forum is on February 24th from 12:00 pm to 6:00 pm with a…

Learn more

Research

MagneGas Corporation (MNGA)

MagneGas Corporation is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification and sterilization of liquid and liquid waste. ($49 USD)

Learn more

Private Markets

SU Labs Accelerator Seed Fund

We're a fiercely passionate community of entrepreneurs leveraging rapidly accelerating technologies to create a brighter future. Join us in fostering innovation, driving impact and funding the future.

FAB Financial Inc.

Banking is broken. Years ago people who needed business advice would turn to their local bank manager for help. The banker was thought of as a trusted member of the…